Keyword Search
Legend:
CC = Baltimore Convention Center, H = Hilton Baltimore
* = applied session ! = JSM meeting theme
|
Keyword Search Criteria: adverse event returned 10 record(s)
|
|
Monday, 07/31/2017
|
Modeling Excess Zeroes in an Integrated Analysis of Vaccine Safety
Roger Maansson, Pfizer Inc.; David Radley, Pfizer Inc.; Qin Jiang, Pfizer Inc.; Scott Patterson, Pfizer Inc.; Judith Absalon, Pfizer Inc.; John Perez, Pfizer Inc.
|
Analysis of Adverse Event Relationships in Clinical Trials Using JMP
Anastasia Dmitrienko; Kelci Miclaus, JMP Life Sciences, SAS Institute Inc.; Richard C. Zink, JMP Life Sciences, SAS Institute, Inc.
|
Inverse Probability of Treatment Weighted Estimator for Exposure Adjusted Incidence Rate Ratio for Rare Adverse Event in Pooled Studies Controlling for Confounding by Study
Hui Wang, Astrazeneca; Sudipta Bhattacharya, AstraZeneca
9:20 AM
|
|
Tuesday, 08/01/2017
|
Discriminant Analysis (DA) Based Methods in Safety Evaluation
Angang Zhang, Merck; Richard Baumgartner, Merck; William W Wang, Merck & Co Inc
|
Discriminant Analysis (DA) Based Methods in Safety Evaluation
Angang Zhang, Merck; Richard Baumgartner, Merck; William W Wang, Merck & Co Inc
9:15 AM
|
Optimal Individualized Early Warning for Inpatient Adverse Events
Hossein Soleimani, Johns Hopkins University; Suchi Saria, Johns Hopkins University
10:35 AM
|
Statistical Methods to Analyze PRO-CTCAE Data in Oncology Clinical Trials
Amylou Dueck, Mayo Clinic
3:05 PM
|
|
|
